Despite a National Deep Brain Stimulation Service in operation since 2022, insufficient resources mean that many Irish ...

GOTHENBURG, SE / ACCESS Newswire / June 4, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, June 4, ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

At its 10th annual Eight Over Eighty gala, health care, business and philanthropic leaders in New York City joined The New ...

INBRIJA, a dopamine replacement therapy for off periods in Parkinson's disease, holds significant market potential due to its ability to provide rapid relief from motor symptoms. With the increasing ...

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, announces the establishment of Japan's first next-gen commercial production site for CAR-T cell ...

DelveInsight's "INBRIJA Market Size, Forecast, and Market Insight Report" highlights the details around INBRIJA, which ...

I am concerned your symptoms are due to Parkinson’s disease,” is something I have said to numerous patients over the years.

The legendary rocker, 76, will take to the stage on July 5, as he performs with Black Sabbath in his native Birmingham at Villa Park for his Back to the Beginning show.

Supernus Pharmaceuticals is expanding its partnership with TV personality and sports reporter Jay Glazer in a new content series featuring his wife, Rosie Glazer. The series, which launches its first ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...